Urinary tract infections with Burkholderia cepacia. A narrative review
Abstract
Burkholderia cepacia is an opportunistic Gram-negative bacillus that is found naturally in soil and water and usually causes respiratory infections in patients with cystic pulmonary fibrosis. Few cases of urinary tract infections with B. cepacia have been described in the literature, all of them clinical case presentations or case series. Therefore, we have compiled the data from the literature on this topic in a review to gain a better understanding of the etiopathogenesis, diagnosis and treatment methods of this disease. B. cepacia can lead to multidrug-resistant urinary tract infections in hospitals when surfaces and medical equipment are contaminated. The diagnosis is made after the onset of postoperative febrile syndrome or prolonged hospitalization in the intensive care unit. The evolution can be unfavorable, with the occurrence of sepsis and increased mortality.
##plugins.themes.bootstrap3.article.details##
B. cepacia, multidrug-resistant germs, urinary tract infections
2. LiPuma JJ. Burkholderia cepacia epidemiology and pathogenesis: implications for infection control. Curr Opin Pulm Med. 1998 Nov;4(6):337-41. doi: 10.1097/00063198-199811000-00005. PMID: 10813212.
3. Du M, Song L, Wang Y, et al. Investigation and control of an outbreak of urinary tract infections caused by Burkholderia cepacian-contaminated anesthetic gel. Antimicrob Resist Infect Control. 2021 Jan 6;10(1):1. doi: 10.1186/s13756-020-00855-x. PMID: 33407871; PMCID: PMC7789005.
4. Holmes A, Govan J, Goldstein R. Agricultural use of Burkholderia (Pseudomonas) cepacia: a threat to human health? Emerg Infect Dis. 1998 Apr-Jun;4(2):221-7. doi: 10.3201/eid0402.980209. PMID: 9621192; PMCID: PMC2640135.
5. Gautam V, Singhal L, Ray P. Burkholderia cepacia complex: beyond pseudomonas and acinetobacter. Indian J Med Microbiol. 2011 Jan-Mar;29(1):4-12. doi: 10.4103/0255-0857.76516. PMID: 21304187.
6. Lu DC, Chang SC, Chen YC, et al. Burkholderia cepacia bacteremia: a retrospective analysis of 70 episodes. J Formos Med Assoc. 1997 Dec;96(12):972-8. PMID: 9444917.
7. Ogundipe OA, Pearson RC, Campbell A. Burkholderia cepacia complex infection complicating long-term urethral catheterisation. BMJ Case Rep. 2019 Nov 14;12(11):e230342. doi: 10.1136/bcr-2019-230342. PMID: 31732540; PMCID: PMC6887370.
8. Angrup A, Kanaujia R, Biswal M, Ray P. Systematic review of ultrasound gel associated Burkholderia cepacia complex outbreaks: Clinical presentation, sources and control of outbreak. Am J Infect Control. 2022 Nov;50(11):1253-1257. doi: 10.1016/j.ajic.2022.02.005. PMID: 35158013.
9. Souza Dias MB, Cavassin LG, Stempliuk V, et al. Multi-institutional outbreak of Burkholderia cepacia complex associated with contaminated mannitol solution prepared in compounding pharmacy. Am J Infect Control. 2013 Nov;41(11):1038-42. doi: 10.1016/j.ajic.2013.01.033. PMID: 23663863.
10. Shi H, Chen X, Chen L, et al. Burkholderia cepacia infection in children without cystic fibrosis: a clinical analysis of 50 cases. Front Pediatr. 2023 May 15;11:1115877. doi: 10.3389/fped.2023.1115877. PMID: 37255574; PMCID: PMC10225540.
11. Dizbay M, Tunccan OG, Sezer BE, Aktas F, Arman D. Nosocomial Burkholderia cepacia infections in a Turkish university hospital: a five-year surveillance. J Infect Dev Ctries. 2009 May 1;3(4):273-7. doi: 10.3855/jidc.124. PMID: 19759490.
12. Farzana R, Jones LS, Rahman MA, et al. Molecular and epidemiological analysis of a Burkholderia cepacia sepsis outbreak from a tertiary care hospital in Bangladesh. PLoS Negl Trop Dis. 2020 Apr 9;14(4):e0008200. doi: 10.1371/journal.pntd.0008200. PMID: 32271750; PMCID: PMC7173934.
13. Kwayess R, Al Hariri HE, Hindy JR, et al. Burkholderia cepacia Infections at Sites Other than the Respiratory Tract: A Large Case Series from a Tertiary Referral Hospital in Lebanon. J Epidemiol Glob Health. 2022 Sep;12(3):274-280. doi: 10.1007/s44197-022-00048-2. PMID: 35773618; PMCID: PMC9470806.
14. Taneja S, Kumar P, Gautam V, et al. Spontaneous Bacterial Peritonitis by Burkholderia cepacia Complex: A Rare, Difficult to Treat Infection in Decompensated Cirrhotic Patients. J Clin Exp Hepatol. 2017 Jun;7(2):102-106. doi: 10.1016/j.jceh.2016.08.008. PMID: 28663673; PMCID: PMC5478935.
15. Ibrahim M, Yap JY. Burkholderia cepacia: a rare cause of bacterial keratitis. BMJ Case Rep. 2018 Apr 25;2018:bcr2018224552. doi: 10.1136/bcr-2018-224552. PMID: 29695396; PMCID: PMC5926555.
16. Jacobson M, Wray R, Kovach D, et al. Sustained endemicity of Burkholderia cepacia complex in a pediatric institution, associated with contaminated ultrasound gel. Infect Control Hosp Epidemiol. 2006 Apr;27(4):362-6. doi: 10.1086/503343. PMID: 16622813.
17. Keizur JJ, Lavin B, Leidich RB. Iatrogenic urinary tract infection with Pseudomonas cepacia after transrectal ultrasound guided needle biopsy of the prostate. J Urol. 1993 Mar;149(3):523-6. doi: 10.1016/s0022-5347(17)36135-9. PMID: 7679757.
18. Ángeles-Garay U, Zacate-Palacios Y, López-Herrera JR, et al. Infecciones urinarias nosocomiales. Contaminación de gel con Burkholderia cepacia [Hospital outbreak of urinary tract infections by lubricant gel contaminated with Burkholderia cepacia]. Rev Med Inst Mex Seguro Soc. 2012 Nov-Dec;50(6):615-22. Spanish. PMID: 23331747.
19. Hakuno H, Yamamoto M, Oie S, Kamiya A. Microbial contamination of disinfectants used for intermittent self-catheterization. Jpn J Infect Dis. 2010 Jul;63(4):277-9. PMID: 20657069.
20. Alvarez-Lerma F, Maull E, Terradas R, et al. Moisturizing body milk as a reservoir of Burkholderia cepacia: outbreak of nosocomial infection in a multidisciplinary intensive care unit. Crit Care. 2008;12(1):R10. doi: 10.1186/cc6778. PMID: 18237375; PMCID: PMC2374635.
21. Shaban RZ, Sotomayor-Castillo C, Nahidi S, et al. Global burden, point sources, and outbreak management of healthcare-associated Burkholderia cepacia infections: An integrative review. Infect Control Hosp Epidemiol. 2020 Jul;41(7):777-783. doi: 10.1017/ice.2020.184. PMID: 32441235.
22. Zeeshan M, Aziz T, Naqvi F. Recurrent urinary tract infection by Burkholderia cepacia in a live related renal transplant recipient. J Pak Med Assoc. 2012 May;62(5):496-8. PMID: 22755318.
23. Sonavane SN, Jamale T, Bose S, Basu S. Multifocal Burkholderia cepacia Infection in Postrenal Transplantation Fever : Role of 18 F-FDG PET/CT in Treatment Optimization. Clin Nucl Med. 2024 Aug 1;49(8):e421-e422. doi: 10.1097/RLU.0000000000005307. PMID: 38861417.
24. Zou Q, Li N, Liu J, et al. Investigation of an outbreak of Burkholderia cepacia infection caused by drug contamination in a tertiary hospital in China. Am J Infect Control. 2020 Feb;48(2):199-203. doi: 10.1016/j.ajic.2019.06.011. PMID: 31345617.
25. Nimri L, Sulaiman M, Hani OB. Community-acquired urinary tract infections caused by Burkholderiacepacia complex in patients with no underlying risk factor. JMM Case Rep. 2017 Jan 31;4(1):e005081. doi: 10.1099/jmmcr.0.005081. PMID: 28348799; PMCID: PMC5361629.
26. Tüfekci S, Şafak B, Nalbantoğlu B, Samancı N, Kiraz N. Burkholderia cepacia complex bacteremia outbreaks among non-cystic fibrosis patients in the pediatric unit of a university hospital. Turk J Pediatr. 2021;63(2):218-222. doi: 10.24953/turkjped.2021.02.005. PMID: 33929111.
27. Sharma-Kuinkel BK, Rude TH, Fowler VG Jr. Pulse Field Gel Electrophoresis. Methods Mol Biol. 2016;1373:117-30. doi: 10.1007/7651_2014_191. PMID: 25682374; PMCID: PMC4582012.
28. Wootton M, Davies L, Pitman K, Howe RA. Evaluation of susceptibility testing methods for Burkholderia cepacia complex: a comparison of broth microdilution, agar dilution, gradient strip and EUCAST disc diffusion. Clin Microbiol Infect. 2020 Nov 28:S1198-743X(20)30708-4. doi: 10.1016/j.cmi.2020.11.012. PMID: 33253940.
29. Eucast - Archive of EUCAST: https://www.eucast.org/fileadmin/src/media/PDFs/EUCAST_files/General_documents/BCC_susceptibility_testing_130719.pdf [Available at 07/272024].
30. Flamm RK, Shortridge D, Castanheira M, Sader HS, Pfaller MA. In Vitro Activity of Minocycline against U.S. Isolates of Acinetobacter baumannii-Acinetobacter calcoaceticus Species Complex, Stenotrophomonas maltophilia, and Burkholderia cepacia Complex: Results from the SENTRY Antimicrobial Surveillance Program, 2014 to 2018. Antimicrob Agents Chemother. 2019 Oct 22;63(11):e01154-19. doi: 10.1128/AAC.01154-19. PMID: 31427295; PMCID: PMC6811394.
31. Vithiya G, Raja S. Burkholderia cepacia infections at sites other than the respiratory tract: A large case series from a tertiary hospital in Madurai. Indian J Med Microbiol. 2023 Sep-Oct;45:100375. doi: 10.1016/j.ijmmb.2023.100375. PMID: 37573045.
32. Li FK, Chan KW, Chan TM, Lai KN. Burkholderia urinary tract infection after renal transplantation. Transpl Infect Dis. 2003 Mar;5(1):59-61. doi: 10.1034/j.1399-3062.2003.00006.x. PMID: 12791077.
33. Radu VD, Ristescu C, Tomac I, et al. Does long preoperative ureteral double J stenting influence the outcomes of retrograde ureteroscopy for ureteral stones? A matched-paired case-control study. Med Surg J. 2021; 125(2):274-9.
34. Balan R, Radu VD, Giușcă SE, et al. A Rare Cause of Massive Hematuria: Placenta Percreta With Bladder Invasion. In Vivo. 2021 Nov-Dec;35(6):3633-3639. doi: 10.21873/invivo.12670. PMID: 34697206; PMCID: PMC8627761.
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Archive of Clinical Cases is protected by copyright and may be used in accordance with copyright and other applicable laws. Content available at www.clinicalcases.eu and our digital applications is intended for personal noncommercial use.
Authors who submit a manuscript for publication in Archive of Clinical Cases agree to the following terms: a. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal. b. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal. c. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) only after the final version of the manuscript was accepted and published, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access). d. It is compulsory that before submission authors ensure that their work was not published in any other medical journals or pending acceptance for publication and that "Archives of Clinical Cases" is the only beneficiary at that moment if their work/case will be accepted by us.
Guidelines for linking to www.clinicalcases.eu a. The main purpose of the site linking to the Archive of Clinical Casess site should be educational. b. Links should be made to the Archive of Clinical Casess home page (www.clinicalcases.eu) or to the articles abstract. c. It is forbidden to use the Archive of Clinical Casess cover by outside organizations unless permission has been granted in advance, notifying our Secretary. d. Material owned by the Archive of Clinical Cases (including the name, logo, cover, and text) may not be used in any manner that may induce the idea or suggest that the Archive of Clinical Cases is in some way recommending a specific company, product or service. e. You must not use or allow others to access or use, all or any part of our Site or the contents and/or applications on it for commercial purposes without our permission. To seek permission to do anything prohibited by or not contained in these TERMS, or which requires our prior consent or agreement, you can contact us.